KPT-330, a potent and selective exportin-1 (XPO-1) inhibitor, shows antitumor effects modulating the expression of cyclin D1 and survivin in prostate cancer models

BACKGROUND AND AIMS: Increased expression of Chromosome Region Maintenance (CRM-1)/exportin-1 (XPO-1) has been correlated with poor prognosis in several aggressive tumors, making it an interesting therapeutic target. Selective Inhibitor of Nuclear Export (SINE) compounds bind to XPO-1 and block its...

Descripción completa

Detalles Bibliográficos
Autores principales: Gravina, Giovanni Luca, Mancini, Andrea, Sanita, Patrizia, Vitale, Flora, Marampon, Francesco, Ventura, Luca, Landesman, Yosef, McCauley, Dilara, Kauffman, Michael, Shacham, Sharon, Festuccia, Claudio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4666032/
https://www.ncbi.nlm.nih.gov/pubmed/26620414
http://dx.doi.org/10.1186/s12885-015-1936-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4666032/
https://www.ncbi.nlm.nih.gov/pubmed/26620414
http://dx.doi.org/10.1186/s12885-015-1936-z

Ejemplares similares